Literature DB >> 7773174

Interleukin-1 beta converting enzyme: a novel cysteine protease required for IL-1 beta production and implicated in programmed cell death.

N A Thornberry1, S M Molineaux.   

Abstract

Interleukin-1 beta converting enzyme is the first member of a new class of cysteine proteases. The most distinguishing feature of this family is a nearly absolute specificity for cleavage at aspartic acid. This enzyme has been the subject of intense research because of its role in the production of IL-1 beta, a key mediator of inflammation. These studies have culminated in the design of potent inhibitors and determination of its crystal structure. The structure secures the relationship of the enzyme to CED-3, the product of a gene required for programmed cell death in Caenorhabditis elegans, suggesting that members of this family function in cell death in vertebrates.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7773174      PMCID: PMC2142972          DOI: 10.1002/pro.5560040102

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  54 in total

1.  Unusual routes of protein secretion: the easy way out.

Authors:  K Kuchler
Journal:  Trends Cell Biol       Date:  1993-12       Impact factor: 20.808

2.  Triosephosphate isomerase catalysis is diffusion controlled. Appendix: Analysis of triose phosphate equilibria in aqueous solution by 31P NMR.

Authors:  S C Blacklow; R T Raines; W A Lim; P D Zamore; J R Knowles
Journal:  Biochemistry       Date:  1988-02-23       Impact factor: 3.162

Review 3.  The IL-1 beta converting enzyme as a therapeutic target.

Authors:  D K Miller; J R Calaycay; K T Chapman; A D Howard; M J Kostura; S M Molineaux; N A Thornberry
Journal:  Ann N Y Acad Sci       Date:  1993-11-30       Impact factor: 5.691

4.  Prevention of vertebrate neuronal death by the crmA gene.

Authors:  V Gagliardini; P A Fernandez; R K Lee; H C Drexler; R J Rotello; M C Fishman; J Yuan
Journal:  Science       Date:  1994-02-11       Impact factor: 47.728

5.  Alpha-diketone and alpha-keto ester derivatives of N-protected amino acids and peptides as novel inhibitors of cysteine and serine proteinases.

Authors:  M R Angelastro; S Mehdi; J P Burkhart; N P Peet; P Bey
Journal:  J Med Chem       Date:  1990-01       Impact factor: 7.446

6.  Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2.

Authors:  D L Vaux; I L Weissman; S K Kim
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

7.  Interleukin 1 beta (IL-1 beta) processing in murine macrophages requires a structurally conserved homologue of human IL-1 beta converting enzyme.

Authors:  S M Molineaux; F J Casano; A M Rolando; E P Peterson; G Limjuco; J Chin; P R Griffin; J R Calaycay; G J Ding; T T Yamin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

8.  The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 alpha and interleukin 1 beta.

Authors:  D J Hazuda; J C Lee; P R Young
Journal:  J Biol Chem       Date:  1988-06-15       Impact factor: 5.157

9.  Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3.

Authors:  M Miura; H Zhu; R Rotello; E A Hartwieg; J Yuan
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

10.  The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme.

Authors:  J Yuan; S Shaham; S Ledoux; H M Ellis; H R Horvitz
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

View more
  41 in total

Review 1.  Hypothalamic mechanisms in cachexia.

Authors:  Aaron J Grossberg; Jarrad M Scarlett; Daniel L Marks
Journal:  Physiol Behav       Date:  2010-03-25

2.  Anthrax lethal toxin-induced inflammasome formation and caspase-1 activation are late events dependent on ion fluxes and the proteasome.

Authors:  Katherine E Wickliffe; Stephen H Leppla; Mahtab Moayeri
Journal:  Cell Microbiol       Date:  2007-09-10       Impact factor: 3.715

3.  Purification and cDNA cloning of a second apoptosis-related cysteine protease that cleaves and activates sterol regulatory element binding proteins.

Authors:  J T Pai; M S Brown; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

Review 4.  [Significance of apoptotic processes in radiotherapy. I].

Authors:  M Abend; D van Beuningen
Journal:  Strahlenther Onkol       Date:  1998-03       Impact factor: 3.621

5.  Cytomegalovirus assemblin: the amino and carboxyl domains of the proteinase form active enzyme when separately cloned and coexpressed in eukaryotic cells.

Authors:  M R Hall; W Gibson
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

6.  Peripheral target regulation of the development and survival of spinal sensory and motor neurons in the chick embryo.

Authors:  J Calderó; D Prevette; X Mei; R A Oakley; L Li; C Milligan; L Houenou; M Burek; R W Oppenheim
Journal:  J Neurosci       Date:  1998-01-01       Impact factor: 6.167

7.  Activation of pro-caspase-7 by serine proteases includes a non-canonical specificity.

Authors:  Q Zhou; G S Salvesen
Journal:  Biochem J       Date:  1997-06-01       Impact factor: 3.857

8.  Activation of CPP32 and Mch3 alpha in wild-type p53-induced apoptosis.

Authors:  J M Chandler; E S Alnemri; G M Cohen; M MacFarlane
Journal:  Biochem J       Date:  1997-02-15       Impact factor: 3.857

Review 9.  Müller cells and diabetic retinopathy.

Authors:  Brandon A Coughlin; Derrick J Feenstra; Susanne Mohr
Journal:  Vision Res       Date:  2017-09-05       Impact factor: 1.886

10.  Caspase-7 activation by the Nlrc4/Ipaf inflammasome restricts Legionella pneumophila infection.

Authors:  Anwari Akhter; Mikhail A Gavrilin; Laura Frantz; Songcerae Washington; Cameron Ditty; Dominique Limoli; Colby Day; Anasuya Sarkar; Christie Newland; Jonathan Butchar; Clay B Marsh; Mark D Wewers; Susheela Tridandapani; Thirumala-Devi Kanneganti; Amal O Amer
Journal:  PLoS Pathog       Date:  2009-04-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.